Breakthrough Approved: FDA Greenlights Revolutionary Six-Month HIV Prevention Drug
Breakthrough Approved: FDA Greenlights Revolutionary Six-Month HIV Prevention Drug In a landmark decision last week, the U.S. Food and Drug Administration (FDA) approved lenacapavir, an innovative antiviral drug for HIV prevention, now marketed as Yeztugo. This approval marks a significant leap forward in the fight against HIV, making a highly effective, long-lasting preventative measure available in the United States. The drug’s development stems directly from the pioneering work of University of Utah biochemist Wesley Sundquist and his lab. For decades,…